|
ISIS Press Release 04/01/06
ISP Reply to Canadian Food
Inspection Agency
On 27 November 2005, Dr. Mae-Wan Ho wrote
to a number of national and international agencies on behalf of the Independent
Science Panel [1] regarding the powerful immune response in test animals fed
genetically modified (GM) peas, demanding a ban on all GM food and feed until
proper assessment on the immunogenicity of all transgenic proteins has been
carried out.
Ho reported the
scientific study [2] in detail, which showed that a previously harmless bean
protein transferred to pea provoked a debilitating immune response on account
of post-translation processing of the protein in the pea plant which differs
from that in bean. As practically every
transgenic protein involves a transfer of the protein to a different species,
all transgenic proteins are potentially capable of provoking such immune reactions,
unless proven otherwise.
The
Canadian Food Inspection Agency (CFIA) responded on 19 December, and the United
States Department of Agriculture Animal and Plant Health Inspection Service
(USDA-APHIS) replied on 22 December.
The
reply from USDA-APHIS explained that while it works in partnership with the
Food and Drug Administration (FDA) and the Environment Protection Agency (EPA)
“to ensure that the development, testing, and use of the products of biotechnology
occur in a manner that is safe for plant and animal health, human health,
and the environment,” it is the FDA that “is responsible for ensuring that
all plant-derived foods and feeds, including those developed through biotechnology
are safe and properly labeled.” And while USDA-APHIS appreciate the information
provided regarding the study, the issues addressed are primarily matters of
food and feed safety, which “fall under the regulatory authority of FDA”,
and suggested that the FDA be contacted directly.
The
CFIA responded with a detailed discussion on the concept of “substantial equivalence” and the procedures used by CFIA, as recommended
by the Food and Agriculture Organization (FAO) [3, 4], to evaluate toxic food
impacts such as allergenicity. The current reply is mainly addressed to the
CFIA.
Many commentators
have exposed the concept of substantial equivalence as thoroughly unscientific,
starting with Ho and Steinbrecher [5], who showed how the concept effectively
allows the approval of GM crops without
the necessary safeguards to human and animal health or the environment.
Similarly, the tests for allergenicity, which
include amino acid sequence similarities, heat stability and digestibility
(mainly under simulated gastric conditions), have already been rightly criticized
as inadequate [6, 7]; and more importantly, do not include the tests carried
out on the transgenic pea in the new study. Even the FAO/WHO reports [3, 4]
recommended a combination of additional methods for assessing allergenicity,
such as binding tests of antisera from allergic patients, and animal exposure
studies.
CFIA
stated: “Characterization data provided
by the proponent is generated with genetically stable, modified
lines that are representative of the final product.” Unfortunately, there
is no evidence that the transgenic lines are genetically stable. In 2003,
French government scientists found that in all five transgenic lines already
commercialised, the GM insert has rearranged since
characterized by the company for commercial approval [8-10].
These
considerations point to the inadequacy of the regulatory regime for GM crops.
Indeed,
the USDA has just been criticised in a report issued by its own Inspector
General for failing to regulate the field trials of GM crops [11, 12]. The
report found that USDA “lacks basic information about the field test sites
it approves and is responsible for monitoring, including where and how the
crops are being grown, and what becomes of them at the end of the field test.”
It also said that weaknesses in regulations and in the internal management
controls at the USDA “increase the risk that genetically engineered organisms
will inadvertently persist in the environment before they are deemed safe
to grow without regulation.”
At the end of the long letter, CFIA noted:
“You cited a recent publication by Prescott et al regarding GM field peas
in your message. We consider this study to be an example of how the appropriate
methods are at hand to identify allergenicity concerns associated with newly
expressed proteins in plants.” It did not say that such methods are actually
being used by the CFIA, however.
It is arguable
whether the tests carried out by Precott et al are adequate for safeguarding
animal and human health, but at least they succeeded in detecting the allergic/hypersensitive
reactions to the transgenic protein. But, none of the transgenic proteins in commercialized
food and feed has been subjected to such tests. CFIA and other
regulatory authorities not only should use similar tests for assessing every
new GM crop, it should retrospectively apply the tests to all already commercialized
GM crops.
That is why,
in the light of the new evidence, a ban on all GM food and feed must be imposed
as a matter of urgency, until and unless the transgenic proteins are proven
safe by adequate tests on immunogenicity.
- “Immune reactions to transgenic protein serious.
Independent scientists demand a ban on GM food & feed while all GM crops
are tested.” ISIS Report 28 November 2005 http://www.i-sis.org.uk/TPTMMI.php
- Prescott
VE, Campbell PM, Moore A, Mattes J, Rothenberg ME, Foster PS, Higgins TJV
and Hogan SP. Transgenic expression of bean a-amylase inhibitor in peas
results in altered structure and immunogenicity. J Agricultural and Food Chemistry 2005,
53, 9023-30.
- Joint FAO/WHO Expert Consultation
on Foods Derived from Biotechnology – Allergenicity of Genetically Modified
Foods – Rome, 22 – 25 January 2001. Rome, Food and Agriculture Organisation of the United Nations, (2001). [http://www.who.int/foodsafety/publications/biotech/en/ ec_jan2001.pdf]
- FAO/WHO: CodexPrinciples
and Guidelines on Foods Derived from Biotechnology, Rome, Italy, Joint FAO/WHO Food Standards Programme (2003) [ftp://ftp.fao.org/codex/standard/en/CodexTextsBiotechFoods.pdf].
- Ho MW and Steinbrecher R. Fatal flaws in food safety
assessment. Critique of the Joint FAO/WHO Biotechnology and Food Safety
Report. Journal of Nutritional and Environmental
Interactions 1998, 2, 1-84.
- Fiers, M.W.E.J., Kleter, G.A., Nijland, H., Peijnenburg,
Ad. A.C.M., Nap, J.P. and van Ham R.C.H.J. BMC Bioinformatics 2004, 5,133. http://www.biomedcentral.com/1471-2105/5/133
- Ho MW, Pusztai A, Bardocz S and Cummins J. Are transgenic
proteins allergenic? Science in Society
2005, 25, 4-5.
- Collonier C, Berthier G, Boyer F, Duplan M-N, Fernandez
S, Kebdani N, Kobilinsky A, Romanuk M, Bertheau Y. Characterization of commercial
GMO inserts: a source of useful material to study genome fluidity. Poster
presented at ICPMB: International Congress for Plant Molecular Biology (n°VII),
Barcelona, 23-28th
June 2003. Poster courtesy of
Pr. Gilles-Eric Seralini, Président du Conseil
Scientifique du CRII-GEN, www.crii-gen.org;
- Ho
MW. Transgenic lines proven unstable. ISIS Report, 23
October 2003 www.i-sis.org.uk;
also Science in Society 2004,
20, 35. http://www.i-sis.org.uk/isisnews.php
- Ho
MW. Unstable transgenic lines illegal. ISIS Report 3 December 2003; also
Science in Society 2004, 21, 23. http://www.i-sis.org.uk/isisnews.php
- “Lax oversight found in tests of gene-altered crops”,
Andrew Pollack, New York Time 3 January 2006. http://www.nytimes.com/2006/01/03/science/03crop.html
- “Report blasts oversight of test fields. Investigators
say the USDA lacks details on what happens with pharma-crops”, Phlip Brasher,
Register Washington Bureau. 30 December 2005.
http://desmoinesregister.com/apps/pbcs.dll/article?AID=/20051230/BUSINESS01/512300334/1030
| |
|